| Urinary tract infection

Targadox vs Zerbaxa

Side-by-side clinical, coverage, and cost comparison for urinary tract infection.
Deep comparison between: Targadox vs Zerbaxa with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsZerbaxa has a higher rate of injection site reactions vs Targadox based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Zerbaxa but not Targadox, including UnitedHealthcare
Sign up to reveal the full AI analysis
Targadox
Zerbaxa
At A Glance
Oral
Daily to twice daily
Tetracycline antibiotic
IV infusion
Every 8 hours
Cephalosporin/beta-lactamase inhibitor
Indications
  • Rocky Mountain Spotted Fever
  • TYPHUS
  • Q Fever
  • Rickettsialpox
  • Respiratory Tract Infections
  • Respiratory Tract Infections
  • Upper Respiratory Infections
  • Urinary tract infection
  • Lymphogranuloma Venereum
  • Psittacosis
  • Trachoma
  • Inclusion conjunctivitis
  • Urethritis
  • Uterine Cervicitis
  • Proctitis
  • non-gonococcal urethritis (NGU)
  • Relapsing Fever
  • Chancroid
  • Plague
  • Tularemia
  • Cholera
  • Campylobacter infection
  • Brucellosis
  • Bartonella Infections
  • Granuloma Inguinale
  • Anthrax disease
  • Gonorrhea
  • Syphilis
  • Yaws
  • Listeriosis
  • Necrotizing Ulcerative Gingivitis
  • Actinomycosis
  • Clostridium Infections
  • Amebiasis
  • Acne Vulgaris
  • Malaria
  • Peritonitis
  • Urinary tract infection
  • Pyelonephritis
  • Hospital acquired pneumonia
  • VABP
Dosing
Adults (general infections) 200 mg on day 1 (100 mg every 12 hours), then 100 mg/day maintenance; 100 mg every 12 hours for severe or chronic Urinary tract infection.
Pediatric patients <45 kg (severe infections) 2.2 mg/kg every 12 hours; for less severe disease (>8 years, <45 kg): 4.4 mg/kg divided into two doses on day 1, then 2.2 mg/kg/day as a single or divided dose. Children >=45 kg receive the adult dose.
Gonorrhea 100 mg twice daily for 7 days; alternate single-visit dose: 300 mg followed by 300 mg 1 hour later, may be taken with food or beverage.
Urethritis, Uterine Cervicitis, Proctitis, non-gonococcal urethritis (NGU) 100 mg twice daily for 7 days.
Syphilis (early, penicillin-allergic patients) 100 mg twice daily for 2 weeks.
Syphilis (>1 year duration, penicillin-allergic patients) 100 mg twice daily for 4 weeks.
Malaria (prophylaxis) Adults: 100 mg once daily beginning 1-2 days before travel, continuing during travel, and for 4 weeks after leaving the malarious area. Pediatric patients >8 years: 2 mg/kg once daily up to the adult dose.
Anthrax disease (inhalational, post-exposure) Adults: 100 mg twice daily for 60 days. Children <45 kg: 2.2 mg/kg twice daily for 60 days; children >=45 kg receive the adult dose.
Peritonitis 1.5 g IV every 8 hours over 1 hour for 4 to 14 days, used in conjunction with metronidazole 500 mg IV every 8 hours; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 5 to 14 days.
Urinary tract infection, Pyelonephritis 1.5 g IV every 8 hours over 1 hour for 7 days; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 7 to 14 days.
Hospital acquired pneumonia, VABP 3 g IV every 8 hours over 1 hour for 8 to 14 days in adult patients 18 years and older.
Contraindications
  • Hypersensitivity to any of the tetracyclines
  • Known serious hypersensitivity to components of ZERBAXA (ceftolozane and tazobactam), piperacillin/tazobactam, or other members of the beta-lactam class
Adverse Reactions
Most common Nausea, vomiting, diarrhea, anorexia, glossitis, dysphagia, enterocolitis, maculopapular and erythematous rashes.
Serious Toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis, anaphylactoid purpura, DRESS, intracranial hypertension, hemolytic anemia, thrombocytopenia, hepatotoxicity, esophagitis, esophageal ulceration, permanent tooth discoloration.
Most common (>=5%) Nausea, diarrhea, headache, pyrexia
Serious Hypersensitivity reactions, Clostridioides difficile-associated diarrhea, intracranial hemorrhage, renal impairment/renal failure, hepatic transaminase increased
Pharmacology
Tetracycline-class antibacterial; doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, exhibiting bacteriostatic activity against a broad range of Gram-positive and Gram-negative bacteria.
Ceftolozane is a cephalosporin antibacterial that inhibits bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs); tazobactam is an irreversible beta-lactamase inhibitor that extends ceftolozane activity against beta-lactamase-producing organisms.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Targadox
  • Covered on 5 commercial plans
  • PA (5/12) · Step Therapy (9/12) · Qty limit (10/12)
View full coverage details ›
Zerbaxa
  • Covered on 5 commercial plans
  • PA (6/12) · Step Therapy (6/12) · Qty limit (0/12)
View full coverage details ›
UnitedHealthcare
Targadox
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Zerbaxa
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Targadox
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (2/3) · Qty limit (2/3)
View full coverage details ›
Zerbaxa
  • Covered on 0 commercial plans
  • PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Targadox.
No savings programs available for Zerbaxa.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
TargadoxView full Targadox profile
ZerbaxaView full Zerbaxa profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.